Next, qPCR analysis revealed that the expression of G6PC3, SLC37A2, and SLC37A4 was considerably higher in all four glioma cell lines tested when compared to HepG2 cells (Figure 4B). The gene discussed is SLC37A4; the disease is central nervous system cancer.